Structural and Genetic Studies Demonstrate Neurologic Dysfunction in TriosephosphateIsomeraseDeficiency Is Associated with Impaired Synaptic Vesicle Dynamics Triosephosphate isomerase (TPI) deficiency is a poorly understood disease characterized by hemolytic anemia, cardiomyopathy, neurologic dysfunction, and early death. TPI deficiency is one of a group of diseases known as glycolytic
Human triosephosphateisomerasedeficiency resulting from mutation of Phe-240. Triosephosphate isomerase (TPI; D-glyceraldehyde-3-phosphate ketolisomerase [E.C.5.3.1.1]) deficiency is an autosomal recessive disorder that typically results in chronic, nonspherocytic hemolytic anemia and in neuromuscular impairment. The molecular basis of this disease was analyzed for one Hungarian family
of these 8,000 mutants were selected using in vivo complementation of a triosephosphateisomerasedeficient strain of E. coli, DF502. Approximately 3% of the mutants complement DF502 with an activity that is above 70% of wild-type activity. The sequences of these hinge mutants reveal that the solutions to the hinge flexibility problem are varied. Moreover, these preferences are sequence dependent